On the 17th of December, the Committee For Medicinal Products for Human Use (CHMP) recommended the grantiing of a marketing authourisation for the medicinal product VAXELIS, an intended prophylaxis against:
- Hepatitis B
- Haemophilius influenza type b
VAXELIS is a combined bacterial and viral vaccine that works by inducing the immune system to mount a specific immune response against the antigens included in its formation. It is for infants and toddlers from the age of 6weeks.
This is a one in kind type of vaccine, as it includes 6 antigens in its formulation. Watch out for VAXELIS!
REFERENCE: EUROPEAN MEDICINES AGENCY.